HG NEF LVGLS ≤ − 14% (n = 118) | HG NEF LVGLS > − 14% (n = 37) | P value | |
---|---|---|---|
Clincal characteristics | |||
Age (years) | 80.5 ± 7.5 | 80.1 ± 6.7 | 0.80 |
Female sex | 57.6% (68/118) | 56.8% (21/37) | 0.93 |
Creatinine clearance (ml/min) | 58 (IQR 35) | 62 (IQR 32) | 0.61 |
Eurolog II (%) | 2.4 ± 2.1 | 2.2 ± 2.4 | 0.98 |
Previous myocardial infarction | 3.6% (4/112) | 9.4% (3/32) | 0.37 |
Hypertension | 68.9% (73/106) | 74.2% (23/31) | 0.74 |
DM2 | 15.5% (16/103) | 21.2% (7/32) | 0.56 |
NYHA I–II | 26.3% (31/118) | 22.2% (8/36) | 0.86 |
NYHA III | 70.3% (83/118) | 75.0% (27/36) | |
NYHA IV | 3.4% (4/118) | 2.8% (1/36) | |
Left atrium and ventricle | |||
EF (%) | 60 ± 6 | 57 ± 4 | 0.004 |
LVGLS (%) | − 18.4 ± 2.8 | − 12.4 ± 1.3 | < 0.0001 |
LVOT Diameter (cm) | 2.0 ± 0.1 | 1.9 ± 0.2 | 0.16 |
LVOT Vmax (m/s) | 1.0 ± 0.2 | 1.0 ± 0.2 | 0.11 |
LVOT VTI (cm) | 25.3 ± 4.9 | 23.4 ± 6.0 | 0.06 |
Stroke Volume Index (mL/m2) | 42.7 ± 9.8 | 37.5 ± 9.5 | 0.005 |
Left Atrial Volume Index (mL/m2) | 44 ± 15 | 51 ± 16 | 0.04 |
Aortic valve | |||
AV Vmax (m/s) | 4.7 ± 0.5 | 4.7 ± 0.6 | 0.90 |
AV Peak Gradient (mmHg) | 89 ± 19 | 89 ± 20 | 0.85 |
AV Mean Gradient (mmHg) | 50 ± 14 | 50 ± 15 | 0.92 |
AV Area (cm2) | 0.7 ± 0.3 | 0.6 ± 0.2 | 0.03 |
AV Area Index (cm2/m2) | 0.4 ± 0.1 | 0.3 ± 0.1 | 0.01 |